<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531842</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#11-110</org_study_id>
    <nct_id>NCT01531842</nct_id>
  </id_info>
  <brief_title>A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye</brief_title>
  <official_title>Bacterial Resistance and Alterations in Conjunctival Flora Following Serial Intravitreal Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mid Atlantic Retina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mid Atlantic Retina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study to evaluate the effects of repeated intravitreal injections on
      bacteria around the eye.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to determine whether conjunctival bacterial flora are
      altered and/or demonstrate increasing antibiotic resistance after serial intravitreal
      injections when a prophylactic topical antibiotic is used pre- and post-injection compared to
      when they are not used.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine if conj bacterial flora demonstrates increased antibiotic resistance if topical antibiotic used pre and post injection vs not used.</measure>
    <time_frame>Prior to each of your eye injections for the first 4 injections and continue through the completion of your fourth injection, an anticipated maximum of 6 months.</time_frame>
    <description>Evaluating the effects of repeated use of iodine drops with or without antibiotic eye drops on bacteria on the eye surface in patients undergoing injections in the eye to determine if conjunctival bacterial floar are altered or demonstate increasing antibiotic resistance.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Central Retinal Vein Occlusion</condition>
  <condition>Choroidal Neovascularization</condition>
  <condition>Age-related Macular Degeneration</condition>
  <condition>Branch Retinal Vein Occlusion</condition>
  <arm_group>
    <arm_group_label>Topical antibiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be randomized in a 1:1 fashion to receive a drop of topical antibiotic before and after the intravitreal injection in the +ABX arm (in addition to the typical prep with betadine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Antibiotic Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No topical antibiotics in the -ABX arm (only the typical prep with betadine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conj flora Antibiotic resistance</intervention_name>
    <description>Patients will either receive a drop of topical antibiotic before and after the intravitral injection or no topical antibiotics (only typical prep with betadine).</description>
    <arm_group_label>Topical antibiotic</arm_group_label>
    <arm_group_label>No Antibiotic Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Subjects will be eligible if the following criteria are met:

          -  Ability to provide written informed consent and comply with study assessments for the
             full duration of the study.

          -  Have been diagnosed with neovascular AMD, CRVO or BRVO.

          -  Have been determined by the investigator to require intravitreal injections of
             bevacizumab or ranibizumab.

        Exclusion Criteria: Subjects meeting any of the following criteria are ineligible for study
        entry:

          -  Prior intraocular injection in either eye.

          -  Chronic use of opthalmic medication.

          -  Contact lens wear.

          -  Ocular surgery within the past 6 months.

          -  Use of ophthalmic medications in either eye or ocular infection within the past 6
             months.

          -  Use of systemic antibiotics within 6 months.

          -  Known allergy or contraindication to povidone iodine or fluoroquinolones.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Hsu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mid Atlantic Retina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wills Eye Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Formoso</last_name>
      <phone>215-928-3092</phone>
    </contact>
    <contact_backup>
      <last_name>Jason Hsu, MD</last_name>
      <phone>215-928-3300</phone>
    </contact_backup>
    <investigator>
      <last_name>Jason Hsu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2011</study_first_submitted>
  <study_first_submitted_qc>February 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2012</study_first_posted>
  <last_update_submitted>February 8, 2012</last_update_submitted>
  <last_update_submitted_qc>February 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mid Atlantic Retina</investigator_affiliation>
    <investigator_full_name>Michele Formoso</investigator_full_name>
    <investigator_title>Research Manager</investigator_title>
  </responsible_party>
  <keyword>Conjunctival bacterial flora</keyword>
  <keyword>prophylactic topical antibiotic</keyword>
  <keyword>injection</keyword>
  <keyword>intravitreal injection</keyword>
  <keyword>bacterial resistance</keyword>
  <keyword>serial injection</keyword>
  <keyword>serial intravitreal injections</keyword>
  <keyword>CNV</keyword>
  <keyword>CRVO</keyword>
  <keyword>AMD</keyword>
  <keyword>BRVO</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
    <mesh_term>Retinal Vein Occlusion</mesh_term>
    <mesh_term>Choroidal Neovascularization</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 18, 2013</submitted>
    <returned>January 8, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

